$415 Million is the total value of DILLON & ASSOCIATES INC's 67 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| DEO | Diageo PLC | $1,768,000 | +3.0% | 12,810 | 0.0% | 0.43% | -8.4% | |
| WMT | Wal-Mart Stores | $1,210,000 | +16.7% | 8,640 | 0.0% | 0.29% | +3.9% | |
| NVS | Novartis AG ADS | $756,000 | 0.0% | 8,689 | 0.0% | 0.18% | -11.2% | |
| NEO | Neogenomics Inc | $296,000 | +19.4% | 8,000 | 0.0% | 0.07% | +6.0% | |
| EMR | Emerson Electric | $258,000 | +6.6% | 3,907 | 0.0% | 0.06% | -6.1% | |
| CLSN | Celsion Corp New | $16,000 | -82.0% | 22,353 | 0.0% | 0.00% | -83.3% | |
| RMTI | Rockwell Medical Tech Inc | $12,000 | -47.8% | 11,494 | 0.0% | 0.00% | -50.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-11-06
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Apple, Inc. | 42 | Q3 2023 | 11.9% |
| Stryker | 42 | Q3 2023 | 6.3% |
| Visa Inc. | 42 | Q3 2023 | 6.5% |
| Abbott Labs | 42 | Q3 2023 | 5.7% |
| Automatic Data Processing | 42 | Q3 2023 | 4.8% |
| PepsiCo | 42 | Q3 2023 | 4.9% |
| Colgate-Palmolive | 42 | Q3 2023 | 5.9% |
| Paychex | 42 | Q3 2023 | 4.3% |
| Air Products | 42 | Q3 2023 | 3.7% |
| Lowe's | 42 | Q3 2023 | 3.9% |
View DILLON & ASSOCIATES INC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-30 |
| 13F-HR | 2024-02-08 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-08 |
| 13F-HR/A | 2023-05-02 |
| 13F-HR | 2023-05-01 |
| 13F-HR | 2023-02-06 |
| 13F-HR | 2022-11-08 |
| 13F-HR | 2022-07-26 |
| 13F-HR | 2022-05-06 |
View DILLON & ASSOCIATES INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.